The global biologics market is entering a dynamic growth phase, shaped by significant advancements in biotechnology, increasing prevalence of chronic diseases, and a rising demand for targeted therapies. Biologics-complex molecules derived from living organisms-are transforming the landscape of modern medicine, enabling more effective and personalized treatments for conditions such as cancer,...